Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results of a Long-Term, Phase 3, Open-Label Extension Trial

20250 citationsJournal Articlehybrid Open Access

Authors

Clinicaltrials.gov identifier: NCT02736656.

Good health and well-being

Published in: CNS Drugs

Volume 39, Issue 11, pp. 1157-1172

Field-Weighted Citation Impact: 0.00